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Objective: To explore the prognostic significance of patient and disease characteristics on the survival of patients
with metastatic cutaneous squamous cell carcinoma of the parotid gland at a tertiary care center in Halifax, Nova
Scotia, Canada.
Methods: A retrospective chart review for all patients diagnosed with metastatic cutaneous squamous cell
carcinoma to the parotid gland from January 2000 to December 2010. Multiple variables were examined related to:
patient demographics, surgical details, non-surgical procedure details, and tumor pathologic description.
Results: A total of 54 patients [48 men (88%) and 6 women (12%)], with a median age at surgery of 78 years (range
47–93 years) were included in the study. All patients had a minimum follow up of 12 months or until deceased,
with a median duration of follow up of 24 months. Predictors that were significant for cancer recurrence were
pretreatment N-stage, pathologic neck node status, total number of positive neck nodes, and perineural invasion.
Predictors that were significant for cancer death were the total number of positive neck nodes and perineural
invasion. The remainder of the predictors including margin status were non-significant. Only age and nodal status
were significant for both cancer death and recurrence on multivariate analysis.
Conclusion: Our results showed only two variables that remained significant on multivariate analysis were age and
number of involved neck nodes, this finding suggests that re-resection of positive margins may not be necessary
and that radiation therapy is the mainstay of treatment for positive margins.
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The parotid gland is anectodermal derivative. During the
development of the ectoderm, the parotid gland harbors
three groups of lymph nodes. The first group is embed-
ded within the parotid fascia, the second is in the par-
otid parenchyma, and the third remains extrafascial and
extraglandular (ex: periauricular). Parotid cancers are
relatively uncommon, representing fewer than 5% of all
head and neck (H&N) cancers [1,2]. In the majority of
cases, the pathological origin is either primary parotid
malignancy or parotid metastasis arising from a cutane-
ous malignancy of the H&N. Squamous cell carcinoma
(SCC) is the second most common subtype of skin* Correspondence: F50_fawaz@hotmail.com
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reproduction in any medium, provided the orcancer after basal cell carcinoma and accounts for 20%
of all nonmelanotic skin cancers in the head and neck
area [3]. The incidence of metastatic cutaneous SCC of
the H&N is low (≈ 5%) [4,5]. Lymphatic spread of H&N
cutaneous SCC often first involves parotid and subse-
quently cervical area lymph nodes [6]. The presence of
nodal metastasis, especially to the parotid lymph nodes,
is an indicator of poor prognosis [7].
There are two different staging systems for metastatic
cutaneous SCC of the parotid: 1) the American Joint
Committee on Cancer (AJCC) and 2) the O’Brien sta-
ging system. The AJCC has been criticized as an inad-
equate staging system for cutaneous SCC. In this system
all patients with regional metastasis are designated N1,
thereby failing to reflect the extent of parotid gland and
cervical lymph node involvement. In 2002, O’Brien et al.
[8] developed a staging system that separates parotidtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(Table 1). A multicenter study has confirmed the super-
iority of the O’Brien staging system to the AJCC as a
prognostic indicator of patients with metastatic cutane-
ous SCC of the parotid gland [9].
There is considerable interest in determining predic-
tors of patient outcome in metastatic cutaneous SCC of
the parotid. Variables include patient demographics (ex:
age, sex), pathology (ex: degree of differentiation, cer-
vical node involvement, intraparotid node involvement,
perineural invasion), and treatment types (ex: surgery
alone, radiation therapy alone, surgery and radiation
therapy, type of parotidectomy, facial nerve preserva-
tion). Combined treatment with surgery and radiation
therapy is the optimum treatment modality and standard
of care for metastatic cutaneous SCC of the H&N
[10,11]. Conversely, evidence of facial nerve involve-
ment, positive margins, and surgery alone without post-
operative radiotherapy have been previously identified as
indicators of poor prognosis [6,12,13].
In this study, our primary aim was to evaluate predictors
of treatment outcome (local recurrence and disease-specific
survival), including effect of margin status (positive, narrow
(≤ 5 mm), negative). Our second aim was to review our
experience with metastatic cutaneous SCC to the parotid at
the Queen Elizabeth II hospital in Halifax, Nova Scotia,
Canada.Methods
A retrospective chart review was performed to identify
all patients diagnosed with metastatic cutaneous SCC to
the parotid gland from January 2000 to December 2010.
Hospital research ethics board committee approval was
obtained. Patients were identified by a medical record
search of the Capital district health authority and ofTable 1 O’Brien et al. system for clinical staging of
metastatic cutaneous SCC involving the parotid gland
O’Brien et al. system for clinical staging of metastatic cutaneous
SCC involving the parotid gland [8]
Parotid
P1 Metastatic node ≤ 3 cm
P2 Metastatic node > 3 cm but ≤ 6 cm or
Multiple parotid nodes
P3 Metastatic node > 6 cm or
Disease involving facial nerve or skull base
Neck
N0 No clinical neck disease
N1 Single ipsilateral neck node ≤ 3 cm
N2 Single node > 3 cm or
Multiple nodes or Contralateral neck nodesCancer Care Nova Scotia. We included all patients aged
18 years and above with pathology proven diagnosis of
metastatic cutaneous SCC to the parotid, having a mini-
mum follow-up of one year, a complete pathology report
including the status of both deep and superficial mar-
gins, and that were treated with curative intent.
All patients were discussed and assessed in multi-
disciplinary head and neck tumor rounds. Treatment
options included either surgery alone or surgery and
radiation therapy (XRT) depending on multiple fac-
tors including tumor margin status, neck node status,
and patients’ general medical health. Surgical inter-
vention ranged from a simple superficial parotidect-
omy with facial nerve sparing without neck dissection
to a total parotidectomy with facial nerve resection
and neck dissection. Parotidectomy with facial nerve
sparing was defined as complete or partial preserva-
tion, allowing for a few branches to be sacrificed as
they were either encased by tumor or demonstrated
paralysis preoperatively.
Data collected included patients demographics (ex:
age, sex), treatment details (ex: surgery only, surgery and
XRT or XRT only), procedure details (type of parotidect-
omy, facial nerve preservation, neck dissection), tumor
characteristics (ex: side, size), pathological description
(ex: degree of differentiation, extra-parotid extension,
perineural invasion, lymphovascular invasion, margin
status both superficial and deep, and neck node status,
number of positive neck nodes, intraparotid lymph node
status ,and number of positive intraparotid lymph
nodes), and outcome data (recurrence, time to recur-
rence, death, time to death, and cause of death). For
each patient two surgical margins were analyzed, super-
ficial and deep. Each margin was reported as negative,
narrow (≤ 5 mm) or positive (Figure 1). In addition to
the superficial and deep margin status, we defined the
combined margin status to be whichever was worse. For
example, if a patient had a positive deep margin and a
negative superficial margin then the combined margin
status was positive. For staging purposes, the O’Brien
staging system was used in this series.
The data were analyzed using the Cox proportional
hazards program (PHREG) in SAS version 9.2 (SAS In-
stitute, Cary, NC). The following variables were investi-
gated for their association with time to cancer
recurrence and time to cancer death: age, sex, diagnosis,
parotidectomy, facial nerve preservation, neck dissec-
tion, P-stage, N-stage, tumor dimension, neck node sta-
tus (binary and 5-point scale [Table 2]), intraparotid
lymph node status (binary and 5-point scale [Table 2]),
extraparotid extension, perineural invasion, lymphovas-
cular invasion, superficial margin status, deep margin
status, combined margin status and radiation therapy.
Univariate and stepwise multivariate approaches were
Figure 1 A: Cauterized parotid tissue with inked surgical
margin in upper part of field. No tumor is present in this image.
B: Fibrotic parotid tissue containing nests of invasive keratinizing
squamous cell carcinoma as close as 2 mm from the surgical
margin. C: Poorly differentiated squamous cell carcinoma replacing
most of the tissue, with involvement of the deep tissue
margin (arrows).
Table 2 Five-point scale for positive neck nodes and
intraparotid lymph nodes
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two 5-point scales were treated as continuous variables in
these analyses. Hazard ratios with 95% confidence inter-
vals and associated p-values were calculated. We report
the results only for variables with p ≤ 0.10. Kaplan-Meier
survival curves were constructed showing the association
between key variables and time to cancer recurrence and
cancer death. Maximum likelihood estimates of the aver-
age times to recurrence and disease specific death (M)
were obtained under the constant hazard assumption by
dividing the total person-time of follow-up by the number
of outcome events.
Results
All results are summarized in Tables 3 and 4.
Study population
The study population included a total of 54 patients [48
men (88%) and 6 women (12%)], with a median age at
surgery of 78 years (range 47–93 years) and a mean age
of 75 years. All patients had a minimum follow up of 12
month or until deceased, with a median duration of fol-
low up of 24 months. All patients had a prior history of
cutaneous SCC of the head and neck. Both neck and
parotid disease were staged using the O’Brien staging
system (Table 1).
Treatment
All patients had parotid surgery for their metastatic cu-
taneous SCC, 34 patients (63%) underwent superficial
parotidectomy and 20 patients (37%) underwent total
parotidectomy. The facial nerve was either fully or par-
tially preserved in 41 patients (76%) and sacrificed in 13
patients (24%). Forty-nine patients underwent neck dis-
section (91%). Radiation therapy was provided to 47
patients (87%) In the remaining seven patients, five
patients did not require radiation therapy and two
patients refused it.
Pathology of metastatic cutaneous SCC
SCC was well differentiated in 3 patients (5%), moder-
ately differentiated in 28 patients (52%), and poorly dif-
ferentiated in 23 patients (43%). The median size of the
Table 3 Univariate analysis for cancer death and recurrence
Variables Cancer death Recurrence
Hazard ratio 95% CI p Hazard ratio 95% CI p
Sex - * - - - - -
Age .94 per year of age .89-.99 .009 .96 per year of age .93-1.01 .064
Degree of differentiation (well, moderate, poor) - - - - - -
Type of parotidectomy(superficial v. total) - - - - - -
Facial nerve preservation (yes v. no) - - - - - -
Neck dissection (yes v. no) - - - - - -
P - Stage (1, 2, 3) 2.59 per unit increase .93-8.33 .067 1.97 .93-4.38 .075
N - Stage (0, 1, 2) 1.85 per unit increase .95-3.58 .069 1.92 1.17-3.11 .011
Tumor dimension (cm) 1.37 .99-1.91 .055 1.24 .98-1.58 .072
Neck node status (yes v. no) 2.70 .75-9.73 .124 3.20 1.24-8.24 .017
Neck node status (5 point scale) 1.46 per unit increase 1.02-2.05 .039 1.49 per unit increase 1.13-1.92 .006
Intraparotid LN status (yes v. no) - - - - - -
Intraparotid LN status (5 point scale) - - - - - -
Extraparotid extension (yes v. no) - - - - - -
Perineural invasion (yes v. no) 5.76 1.08-106.3 .039 3.26 1.07-14.1 .036
Lymphovascular invasion (yes v. no) - - - - - -
Superficial margin status (negative, narrow, positive) - - - - - -
Deep margin status (negative, narrow, positive) - - - - - -
Combined margin status (negative, narrow, positive) - - - 1.82 .95-4.07 .073
Radiation therapy (yes v. no) - - - - - -
* Hyphens (−) were inserted in the table when p>.1.
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teen patients (30%) had clinically positive neck nodes,
while 38 patients (70%) had no evidence of neck disease.
In terms of intraparotid lymph nodes, 30 patients (56%)
had only a single node involved and 24 patients (44%)
had multiple intraparotid nodes affected. Neck disease
was staged as N0 in 38 patients (70%), N1 in 3 patients
(6%), and N2 in 13 patients (24%). Parotid disease was
staged as P1 in 9 patients (16%), P2 in 29 patients (54%),
and P3 in 16 patients (30%). Extraparotid extension was
positive in 45 patients (83%). Perineural invasion was
positive in 35 patients (65%). Lymphovascular invasion
was positive in 15 patients (28%). Margin status is sum-
marized in Table 5.
Outcome data
The overall recurrence rate was 33% (18 of 54). Median
time to recurrence was 4.5 months (range 1.5-12Table 4 Multivariate analysis for cancer death and recurrence
Predictor Death from cancer
Hazard ratio 95% CI
Age .92 per year of age .86-.97
Nodal status (5 point scale) 1.72 Per unit increase 1.19-2.44months) (Figure 2). All recurrences were in patients who
had both surgery and radiation therapy, except 2
patients who refused radiation therapy after surgery. The
2-year recurrence free survival rate was 60% (32 of 54
patients). The two-year overall survival rate was 70% (38
of 54 patients) and the two-year disease specific survival
rate was 81% (44 of 54 patients). The total number of
deaths were 16 (30%), 10 deaths (19%) were cancer
related and 6 deaths (11%) were non-cancer related
(Figure 2).
On univariate analysis, variables that were significant for
recurrence were the presence of neck disease (p = 0.017)
(Figure 3b), higher N staging for neck disease (p = 0.011),
and the presence of perineural invasion (p = 0.036)
(Figure 3d). Subdivision of patients into 5 groups (Table 2)
based on the number of positive nodes (0, 1, 2, 3, 4+)
demonstrated higher recurrence with increased nodal
involvement (p = 0.006). In patients with negative neckRecurrence
p Hazard ratio 95% CI p
.002 .95 per year of age .91-.99 .014
.003 1.58 Per unit increase 1.20-2.05 .001
Table 5 Margin status distribution summary
Negative Narrow (< 5 mm) Positive Total
Superficial M. 36 14 4 54
Deep M. 13 13 28 54
Combined M. 12 13 29 54
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years, whereas in patients with positive neck nodes was
1.9 years (Figure 3b). For perineural invasion the average
time to recurrence (M) was 3.5 years in patients with posi-
tive perineural invasion and 15.2 years in patients were
perineural invasion was absent (Figure 3d). All other
variables including margin status (superficial, deep and
combined) (Figure 3f) were not statistically significant for
recurrence.
On the other hand, variables that were significant on
univariate analysis for cancer death were the presence of
perineural invasion (p = 0.039) (Figure 3c) and increased
number of positive neck nodes (p = 0.039). The average
time to disease-specific death (M) was 8.1 years with
positive perineural invasion and 49.8 years in the ab-
sence of perineural invasion. Our data also showed a de-
crease in cancer death in the elderly (p = 0.009)
(Figure 3g). The average time to disease-specific death
(M) was 25.6 years in patients above 75 years of age and
6.5 years in patients below the age of 75 years. The other
variables, including margin status (superficial, deep, and
combined) (Figure 3e) and P stage were not statistically
significant for recurrence or cancer death on univariate
analysis.
Only age and neck nodes status were significant on
multivariate analysis. Older patients and those with
fewer positive neck nodes had significantly better
prognosis than younger patients and those with a
higher number of positive nodes. No other variable
met the 0.1 (or even 0.2) significance level for entry into
the model (Table 4).Figure 2 Overall disease-specific and recurrence free survival.Discussion
Sun exposed areas of the head and neck are some of the
most common involved sites with cutaneous malignancy
(squamous cell carcinoma, basal cell carcinoma, and
melanoma). Although metastases from cutaneous SCC
are uncommon, their presence especially in neck and/or
intraparotid lymph nodes is an indicator of aggressive-
ness and poor prognosis. The relatively low frequency of
metastatic spread of cutaneous SCC to the parotid and
or neck lymph nodes is the main obstacle in being able
to perform a retrospective study investigating the effect
of certain variables on patient outcome. The highest in-
cidence of cutaneous squamous cell carcinoma (SCC) in
the world is in Australia with an annual incidence of
over 300 cases per 100 000 people [14]. In this retro-
spective study we analyzed data on all patients operated
in our institution with metastatic cutaneous SCC to the
parotid and treated with curative intent. We also ana-
lyzed the impact of several predictors on the rates of
recurrence and cancer deaths. Several factors have been
shown previously to predict local recurrence such as
involved margins [15], poorly differentiated SCC, dia-
meter > 2 cm, depth > 4 mm, perineural invasion, and
absence of adjuvant radiotherapy [6].
In our series, most patients were treated with both
surgery and radiation therapy. Only 7 out of the 54
patients did not get radiation therapy. In 5 patients radi-
ation therapy was not indicated (negative margin, no
neck node involvement, negative perineural invasion,
negative lymphovascular invasion and metastatic parotid
node is ≤ 3 cm) and none of these patients had recur-
rence. The other 2 patients refused radiation therapy
despite having involved margins and positive neck
nodes. Studies have proven that metastatic cutaneous
SCC to the parotid is best treated with surgery and post-
operative radiation therapy [10-12].
In this retrospective study we did investigate the effect
of multiple predictors on local recurrence and cancer
Figure 3 a: Disease-specific survival by nodal status. b: Recurrence free survival by nodal status. c: Disease-specific survival by perineural
invasion. d: Recurrence free survival by perineural invasion. e: Disease-specific survival by combined margin status. f: Recurrence free survival by
combined margin status. g: Disease-specific survival by age group. h: Recurrence free survival by age group.
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Table 6 The number and percentage of each margin










Negative (12) (22%) 10 (84%) 1 (8%) 1 (8%)
Narrow (13) (24%) 7 (54%) 4 (30%) 2 (16%)
Positive (29) (54%) 9 (31%) 13 (45%) 7 (24%)
Total (54) (100%) 26 18 10
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gist labeled as either superficial or deep margins. Super-
ficial margins can be include either skin margins if the
tumor involves the skin or from the most superolateral
margin of the tumor resection. Deep margin are princi-
pally from the tumor resection bed. Margin status was
reported as negative, positive, or narrow if within 5 mm.
There was no significant difference in local recurrence
or cancer death rates when comparing patients with
positive margins to others with either negative or narrow
margins. The combined margin status category, which is
the worst status of either the deep or superficial margin,
was also not statistically significant. However looking at
the rates of each margin status in Table 6 there is an in-
crease in the rates of recurrence and cancer death when
comparing negative, narrow, and positive margins. This
is most likely due to the relatively small patient numbers
in each group our data didn’t reach statistical signifi-
cance. In 1995, Khurana et al. has noted that positive
surgical margins were associated with poorer local dis-
ease control (P < 0.05). Some recent studies demon-
strated that positive margins do increase in the rate of
recurrence [12], while others refuted this [13]. However,
all previously published studies are in agreement that
postoperative radiation therapy decreases the rate of re-
currence in patients with involved margins [12,13].
The O’Brien staging system was used in this study ra-
ther than the AJCC staging system as it has been proven
to be superior in predicting patient prognosis (Table 1).
The P- and N- stages did not show statistical signifi-
cance in the rates of cancer death, p-value at 0.067 and
0.069 respectively. In terms of recurrence rates, N-stage
was statistically significant, p-value 0.011, but not P-
stage. In 2008, Hinerman et al. showed statistically sig-
nificant difference in local and loco-regional control and
disease free survival when separated by clinical P-stage
but not N-stage [12]. We also investigated the effect of
an increase in number of positive neck or intraparotid
lymph nodes as a continuous variable, and that did show
significant increase in the rate of both cancer death (p =
0.039) and recurrence (p = 0.006) with an increasing
number of positive neck nodes, but not intraparotid
nodes. Kelder et al. [16] did similar analysis investigatingthe effect of increase in the number of positive lymph
nodes on overall survival and disease free survival, which
was significant with a p value of < 0.001.
Perineural invasion on univariate analysis was asso-
ciated with a significant increase in both the rate of can-
cer death and recurrence. However, the effect of the
other pathological variables (ex: lymphovascular invasion
and extraparotid extension) did not show any signifi-
cance neither in cancer death or recurrence. In our ana-
lysis, elderly patients were associated with significant
decrease in the rate of cancer death (p = 0.009) (Figure 3g).
The average time to disease-specific death (M) was 25.6
years in patients above 75 years of age and 6.5 years in
patients below the age of 75 years. This might be an
incidental finding or might correlate with a less aggressive
in elderly. The only two variables that remained significant
on multivariate analysis were age and number of involved
neck nodes, which showed that older patients and those
with fewer neck nodes involvements had significantly bet-
ter prognosis than younger patients and those with a
higher number of positive nodes for both disease-specific
survival and recurrence free survival.Conclusion
Metastatic cutaneous SCC to the parotid is an aggressive
disease. Prognosis is poor and ranges between 30% and
75% [17,18]. Neck disease, higher N-stage, larger num-
ber of positive neck nodes, and perineural invasion were
associated with higher risk of recurrence. The risk of
cancer death was higher with perineral invasion, higher
number of positive neck nodes and patients younger
than 75 years of age.
Despite previous reports on margin status affecting
outcomes in metastatic SCC of the parotid, this study
found the only two variables that remained significant
on multivariate analysis were age and number of in-
volved neck nodes, This finding suggests that re-
resection of positive margins may not be necessary and
that radiation therapy is the mainstay of treatment for
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